Differential expression of selected histone modifier genes in human solid cancers
- PMID: 16638127
- PMCID: PMC1475574
- DOI: 10.1186/1471-2164-7-90
Differential expression of selected histone modifier genes in human solid cancers
Abstract
Background: Post-translational modification of histones resulting in chromatin remodelling plays a key role in the regulation of gene expression. Here we report characteristic patterns of expression of 12 members of 3 classes of chromatin modifier genes in 6 different cancer types: histone acetyltransferases (HATs)- EP300, CREBBP, and PCAF; histone deacetylases (HDACs)- HDAC1, HDAC2, HDAC4, HDAC5, HDAC7A, and SIRT1; and histone methyltransferases (HMTs)- SUV39H1and SUV39H2. Expression of each gene in 225 samples (135 primary tumours, 47 cancer cell lines, and 43 normal tissues) was analysedby QRT-PCR, normalized with 8 housekeeping genes, and given as a ratio by comparison with a universal reference RNA.
Results: This involved a total of 13,000 PCR assays allowing for rigorous analysis by fitting a linear regression model to the data. Mutation analysis of HDAC1, HDAC2, SUV39H1, and SUV39H2 revealed only two out of 181 cancer samples (both cell lines) with significant coding-sequence alterations. Supervised analysis and Independent Component Analysis showed that expression of many of these genes was able to discriminate tumour samples from their normal counterparts. Clustering based on the normalized expression ratios of the 12 genes also showed that most samples were grouped according to tissue type. Using a linear discriminant classifier and internal cross-validation revealed that with as few as 5 of the 12 genes, SIRT1, CREBBP, HDAC7A, HDAC5 and PCAF, most samples were correctly assigned.
Conclusion: The expression patterns of HATs, HDACs, and HMTs suggest these genes are important in neoplastic transformation and have characteristic patterns of expression depending on tissue of origin, with implications for potential clinical application.
Figures



Similar articles
-
Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.Anticancer Res. 2011 Dec;31(12):4115-25. Anticancer Res. 2011. PMID: 22199269
-
Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer.Am J Physiol Lung Cell Mol Physiol. 2016 Dec 1;311(6):L1245-L1258. doi: 10.1152/ajplung.00253.2016. Epub 2016 Oct 28. Am J Physiol Lung Cell Mol Physiol. 2016. PMID: 27793800 Free PMC article.
-
Abnormal histone modification patterns in lupus CD4+ T cells.J Rheumatol. 2008 May;35(5):804-10. Epub 2008 Apr 1. J Rheumatol. 2008. PMID: 18398941
-
Cancer genetics of epigenetic genes.Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R28-49. doi: 10.1093/hmg/ddm021. Hum Mol Genet. 2007. PMID: 17613546 Review.
-
Histone modification enzymes: novel targets for cancer drugs.Expert Opin Emerg Drugs. 2004 May;9(1):135-54. doi: 10.1517/eoed.9.1.135.32947. Expert Opin Emerg Drugs. 2004. PMID: 15155140 Review.
Cited by
-
Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.Mol Cell Biochem. 2016 Apr;415(1-2):183-96. doi: 10.1007/s11010-016-2690-5. Epub 2016 Mar 18. Mol Cell Biochem. 2016. PMID: 26992905
-
Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma.Sci Rep. 2016 Mar 4;6:22622. doi: 10.1038/srep22622. Sci Rep. 2016. PMID: 26940009 Free PMC article.
-
Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.Cancer Res. 2011 Jun 1;71(11):3921-31. doi: 10.1158/0008-5472.CAN-10-3358. Epub 2011 Apr 14. Cancer Res. 2011. PMID: 21493592 Free PMC article.
-
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond.Front Pharmacol. 2022 Sep 15;13:946811. doi: 10.3389/fphar.2022.946811. eCollection 2022. Front Pharmacol. 2022. PMID: 36188615 Free PMC article. Review.
-
Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.Nutrients. 2018 Nov 16;10(11):1784. doi: 10.3390/nu10111784. Nutrients. 2018. PMID: 30453545 Free PMC article.
References
-
- Santos-Rosa H, Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur J Can. 2005. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous